Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease
Resolvins are endogenous lipids with pro-resolving activity. Here the authors find that rats overexpressing human α-synuclein show defects in dopamine signalling before dopamine cell loss, and that this is associated with low Resolvin D1 levels and neuroinflammation.
Main Authors: | Paraskevi Krashia, Alberto Cordella, Annalisa Nobili, Livia La Barbera, Mauro Federici, Alessandro Leuti, Federica Campanelli, Giuseppina Natale, Gioia Marino, Valeria Calabrese, Francescangelo Vedele, Veronica Ghiglieri, Barbara Picconi, Giulia Di Lazzaro, Tommaso Schirinzi, Giulia Sancesario, Nicolas Casadei, Olaf Riess, Sergio Bernardini, Antonio Pisani, Paolo Calabresi, Maria Teresa Viscomi, Charles Nicholas Serhan, Valerio Chiurchiù, Marcello D’Amelio, Nicola Biagio Mercuri |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2019-09-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-019-11928-w |
Similar Items
-
Author Correction: Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease
by: Paraskevi Krashia, et al.
Published: (2019-10-01) -
Unifying Hypothesis of Dopamine Neuron Loss in Neurodegenerative Diseases: Focusing on Alzheimer's Disease
by: Paraskevi Krashia, et al.
Published: (2019-05-01) -
The VTA dopaminergic system as diagnostic and therapeutical target for Alzheimer's disease
by: Paraskevi Krashia, et al.
Published: (2022-10-01) -
Dysregulation of Resolvin E1 Metabolism and Signaling in a Light-Damage Model of Age-Related Macular Degeneration
by: Annamaria Tisi, et al.
Published: (2023-04-01) -
Dopamine loss alters the hippocampus-nucleus accumbens synaptic transmission in the Tg2576 mouse model of Alzheimer's disease
by: Alberto Cordella, et al.
Published: (2018-08-01)